as on March 13, 2026 at 9:31 pm IST
Day's Low
Day's High
1.69%
Downside
1.69%
Upside
52 Week's Low
52 Week's High
3.39%
Downside
83.05%
Upside
as on March 13, 2026 at 4:01 pm IST
Market Cap
₹53.25 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0P/B Ratio
1.12
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-248.39
EPS (TTM)
0Sector
Finance
Book Value
0Compare market cap, revenue, PE, and other key metrics of Biogen Pharmachem with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 53.25 | 36.19% | 0.00 | -1 | 1 | |
| NA | 164.94 | 55.27% | 0.00 | 13 | 82 | |
| NA | 495.62 | 0.93% | 0.69 | 45 | 361 | |
| BUY | 10,296.38 | 19.36% | 0.00 | 382 | 1,539 | |
| NA | 483.10 | 260.59% | 0.00 | 22 | 77 |
Investment in Biogen Pharmachem Industries Ltd Shares on INDmoney has dropped by -27.61% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Biogen Pharmachem Industries Ltd Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Biogen Pharmachem.
Biogen Pharmachem Industries Ltd’s net profit jumped 248.39% since last year same period to ₹0.46Cr in the Q3 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 193.88% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, BSE Ltd has given 1823.1% return, outperforming this stock by 1832.2%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 100.00% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, BSE Ltd has given 115.8% return, outperforming this stock by 155.2%
Price Dip
![]()
In the last 7 days, Biogen Pharma stock has moved down by -3.2%
| Organisation | Biogen Pharmachem Industries Ltd |
| Industry | Finance |
| CEO | Niraj Vaghela |
| E-voting on shares | Click here to vote |
Biogen Pharmachem share price today stands at ₹0.59 as on at the close of the market. Biogen Pharmachem share today touched a day high of ₹0.6 and a low of ₹0.58.
Biogen Pharmachem touched a 52 week high of ₹1.08 and a 52 week low of ₹0.57. Biogen Pharmachem share price today i.e. is closed at ₹0.59, which is -45.37% down from its 52 week high and 3.51% up from its 52 week low.
Biogen Pharmachem market capitalisation is ₹53.25 Cr as on .
To buy Biogen Pharmachem shares, you need to follow these steps:
Biogen Pharmachem trading volume is 17.34L as on . This means that 17.34L shares of Biogen Pharmachem were bought and sold on the stock market during today's trading session.